Managers / Q1 2026
C V STARR & CO INC
CIK 0001340459 · 399 PARK AVE 17TH FL, NEW YORK, NY, 10022 · 212-230-5050
Summary
C V Starr & Co Inc reported $192M in U.S.-listed holdings across 5 positions for Q1 2026.
The portfolio is heavily concentrated: GQ9 alone accounts for 56.4% of reported value.
The book was largely unchanged from Q4 2025.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 99.5% · $191M
- Common Stock · 0.5% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GQ9SPDR GOLD TR | HELD | +0 | 251.4K | +$9M | $108M |
| ISHARES TR | HELD | +0 | 200.5K | +$827,892 | $25M |
| VANGUARD INDEX FDS | HELD | +0 | 227.4K | +$573,116 | $26M |
| CELUCELULARITY INC | HELD | +0 | 764.1K | −$565,411 | $1M |
| ISHARES TR | HELD | +0 | 378.8K | +$412,878 | $32M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | GQ9SPDR GOLD TRhistory → | SPDR GOLD | 56.41% | $108M | 251.4K |
| 2 | ISHARES TR | CORE MSCI INTL DM · CORE S&P SM-CP | 29.50% | $57M | 579.2K |
| 3 | VANGUARD INDEX FDS | S&P MC 400 | 13.56% | $26M | 227.4K |
| 4 | CELUCELULARITY INC | CL A NEW | 0.53% | $1M | 764.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $192M | 5 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $182M | 5 | Feb 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $217M | 5 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $192M | 5 | Aug 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $130M | 5 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $128M | 6 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $5M | 2 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $8M | 2 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $7,836 | 2 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 2 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $21M | 2 | Oct 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $29M | 2 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $71M | 2 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $27M | 2 | Jan 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $5M | 1 | Nov 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $5M | 1 | Jul 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $5M | 1 | Apr 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $5M | 1 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $5M | 1 | Oct 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $4M | 1 | Jul 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $16M | 11 | Apr 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $30M | 10 | Jan 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $29M | 10 | Oct 11, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $31M | 10 | Jul 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $31M | 10 | Apr 25, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $18M | 9 | Feb 1, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.